During Wednesday’s Current trade, Shares of Fossil Group Inc (NASDAQ:FOSL), gain 0.03% to $62.26.
Fossil Group, Inc. (FOSL) stated its financial results for the fiscal quarter ended July 4, 2015. In the second quarter of fiscal 2015, the translation impact from the strengthening of the U.S. dollar negatively influenced net sales by $50.9 million and reduced diluted EPS by $0.30. On a constant currency basis, second quarter net sales raised 2%.
Second Quarter Fiscal 2015 Revenue Summary
In the second quarter of fiscal 2015, stated worldwide net sales reduced 4% or $33.8 million driven by the negative impact of changes in foreign currency. The following table provides a summary of net sales performance contrast to the second quarter of fiscal 2014.
The Company stated net income for the second quarter of fiscal 2015 of $54.6 million contrast to $52.5 million for the second quarter of fiscal 2014. Diluted earnings per share were $1.12, contrast to $0.98 for the second quarter of fiscal 2014. In constant currency, diluted earnings per share for the second quarter of fiscal 2015 were $1.42, counting a restructuring charge of $0.10 per diluted share. The favorable earnings per share impact of the comparable 2% sales growth, non-operating gains and a lower share base combined to drive the enhance in diluted earnings per share.
Fossil Group, Inc., together with its auxiliaries, designs, develops, markets, and distributes consumer fashion accessories. The company operates through four segments: North America Wholesale, Europe Wholesale, Asia Pacific Wholesale, and Direct to Consumer. The company’s principal products comprise a line of men’s and women’s fashion watches and jewelry, handbags, small leather goods, belts, sunglasses, soft accessories, and selected apparel.
Shares of Cerus Corporation (NASDAQ:CERS), declined -2.36% to $4.97, during its current trading session.
Cerus Corporation (CERS) declared that Unyts has signed a three-year purchase agreement for the INTERCEPT Blood System for platelets and plasma. Unyts provides blood components to eight counties in Western New York, supplying about 5,000 platelet and 11,000 plasma units per year.
Cerus Corporation operates as a biomedical products company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System is based on its proprietary technology for controlling biological replication and designed to target and inactivate blood-borne pathogens, counting viruses, bacteria, and parasites, in addition to potentially harmful white blood cells, while preserving the therapeutic properties of platelet, plasma, and red blood cell transfusion products.
Legacy Reserves LP (NASDAQ:LGCY), during its Wednesday’s current trading session decreased -1.54% to $5.76.
Legacy Reserves LP (LGCY), declared that Dan Westcott, Executive Vice President and Chief Financial Officer, and Kyle Hammond, Executive Vice President and Chief Operating Officer, will take part at the 2015 Citi MLP Conference in Las Vegas on Thursday, August 20, 2015.
Legacy Reserves LP owns and operates oil and natural gas properties in the United States. As of December 31, 2014, the company owned interests in producing oil and natural gas properties in 665 fields comprising 11,121 gross productive wells, counting 3,919 operated and 7,202 non-operated wells located in the Permian Basin, Texas Panhandle, Wyoming, North Dakota, Montana, the Piceance Basin of Colorado, Oklahoma, and other states.
Finally, Raytheon Company (NYSE:RTN), decreased -0.82%, to $109.42.
Raytheon Company (RTN) declared net sales for the second quarter 2015 were $5.8 billion contrast to $5.7 billion in the second quarter 2014. Second quarter 2015 EPS from ongoing operations was $1.65 contrast to $1.59 in the second quarter 2014. Second quarter 2015 EPS from ongoing operations comprised of a favorable FAS/CAS Adjustment of $0.10 contrast to a favorable FAS/CAS Adjustment of $0.18 in the second quarter 2014. In addition, second quarter 2015 EPS from ongoing operations comprised of, as predictable, a $0.29 favorable impact from a tax settlement.
The Company had bookings of $7.6 billion in the second quarter 2015, resulting in a book-to-bill ratio of 1.30. In the second quarter 2014, bookings were $6.8 billion. Year-to-date 2015 bookings were $12.1 billion, resulting in a book-to-bill ratio of 1.08. Year-to-date 2014 bookings were $11.1 billion.
Raytheon Company develops integrated products, services, and solutions in the areas of sensing; effects; command, control, communications, and intelligence; mission support; and cyber and information security worldwide. It operates in four segments: Integrated Defense Systems (IDS); Intelligence, Information, and Services (IIS); Missile Systems (MS); and Space and Airborne Systems (SAS). The IDS segment provides integrated air and missile defense; radar solutions; naval combat and ship electronic systems; command, control, communications, computers, and intelligence solutions; and air traffic administration systems.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
